Modelling the progression of illicit substance use patterns from real-world evidence

被引:1
|
作者
Tummala, Hari Prabhath [1 ]
Bies, Robert R. [1 ]
Ramanathan, Murali [1 ,2 ]
机构
[1] Univ Buffalo State Univ New York, Dept Pharmaceut Sci, Buffalo, NY USA
[2] SUNY Buffalo, Dept Pharmaceut Sci, 355 Pharm Bldg, Buffalo, NY 14214 USA
关键词
addiction; disease modeling; drug abuse; pharmacometrics; substance use disorder; MULTISTATE MODELS; OPIOID USE; TRAJECTORIES; SURVIVAL; DRUG; ADDICTION;
D O I
10.1111/bcp.15965
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AimsTo investigate an innovative pharmacometrics approach that addresses the challenges of using real-world evidence to model the progression of illicit substance use.MethodsThe modelling strategy analysed real-world data from the National Longitudinal Study of Adolescent to Adult Health (AddHealth) survey using survival analyses and differential equations. Respondents were categorized into drug-naive, active users and nonusers. The transitions between categories were modelled using interval-censored parametric survival analysis. The resulting hazard rate functions were used as time-dependent rate constants in a differential equation system. Covariate models for sex and depression status were assessed.ResultsAddHealth enrolled 6504 American teenagers (median age 16 years, range 11-21 years); this cohort was followed with five interviews over a 22-year period; the median age at the last interview was 38 years (range 34-45 years). The percentages of illicit drug users at Interviews 1-5 were 7.7%, 5.9%, 15.8%, 21.4% and 0.98%, respectively. The generalized gamma distribution emerged as the preferred model for the survival functions for transitions between categories. Age-dependent prevalence was obtained from the differential equation system. Active drug use was more prevalent in males, increased in adolescence and college years, peaked at 24 years, and decreased to low levels by 35 years. Depression, which was more frequent in females, increased the drug-naive-active user transition rates but not the active user-nonuser and nonuser-active user transition rates. The evidence did not support an interaction between sex and depression.ConclusionsThe model provided a satisfactory approximation for the age-dependent progression of illicit substance use from preadolescence to early middle age.
引用
收藏
页码:700 / 712
页数:13
相关论文
共 50 条
  • [1] Understanding illicit substance use in the real world
    Ciccarone, Dan
    Jain, Sharad
    Bourgois, Philippe
    MEDICAL EDUCATION, 2008, 42 (05) : 532 - 532
  • [2] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [3] Progression of prediabetes with and without metformin: Real-world evidence
    Polisetti, S.
    Tippisetty, S.
    Reddy, S.
    Seshadri, K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [4] Treatment Patterns in Essential Tremor: Real-World Evidence from Germany
    Becktepe, J. S.
    Mueller, S.
    Wilke, T.
    Zhuleku, E.
    Appiah, K.
    McDonald, K.
    Dzimitrowicz, N.
    Marshall, J.
    Sabater, J.
    Barbato, L. M.
    Saifee, A.
    MOVEMENT DISORDERS, 2024, 39 : S723 - S723
  • [5] A Statistical Roadmap for Journey from Real-World Data to Real-World Evidence
    Yixin Fang
    Hongwei Wang
    Weili He
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 749 - 757
  • [6] A Statistical Roadmap for Journey from Real-World Data to Real-World Evidence
    Fang, Yixin
    Wang, Hongwei
    He, Weili
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (04) : 749 - 757
  • [7] REAL-WORLD EVIDENCE ON THE RISE: EVALUATING THE USE OF REAL-WORLD EVIDENCE IN ICER ASSESSMENTS OF COMPARATIVE CLINICAL EFFECTIVENESS
    Drane, E.
    Upton, E.
    Morten, P.
    Walker, E.
    VALUE IN HEALTH, 2019, 22 : S316 - S316
  • [8] Insights from Real-World Evidence on the Use of Inhalers in Clinical Practice
    Rubio, Myriam Calle
    Teppa, Pedro Jose Adami
    Hermosa, Juan Luis Rodriguez
    Carro, Miriam Garcia
    Martinez, Jose Carlos Tallon
    Rubio, Consolacion Riesco
    Cortes, Laura Fernandez
    Duenas, Maria Morales
    del Barrio, Valeria Chamorro
    Sanchez-del Hoyo, Rafael
    Aragon, Jorge Garcia
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [9] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [10] The Use of Real-world Data to Generate Real-world Evidence to Accelerate Neonatal Drug Development
    Jackson, Shawn S.
    Cravero, Joseph P.
    Sun, Lena
    Davis, Jonathan M.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2025, 37 (01) : 110 - 113